TrialAmerican journal of hematology2015

Phase I/II trial of the combination of midostaurin (PKC412) and 5-azacytidine for patients with acute myeloid leukemia and myelodysplastic syndrome.

Paolo Strati et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.